BioSapien is a biotech startup that provides a drug delivery platform to deliver drugs for cancer treatment.
BioSapien has raised $8.0M in total funding. The most recent round was Seed. The last funding was announced in December 2024.
BioSapien's investors include National Science Foundation, Golden Gate Ventures, SOSV, Global Ventures, Side Door Ventures.
BioSapien is headquartered in San Diego, United States.
BioSapien is a biotech startup that provides a drug delivery platform to deliver drugs for cancer treatment.
BioSapien is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BioSapien — Funding & Investors." VCBacked, December 13, 2024, https://www.vcbacked.co/company/biosapien. Accessed September 30, 2026.
VCBacked. (2024). BioSapien — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/biosapien
{{cite web |title=BioSapien — Funding & Investors |url=https://www.vcbacked.co/company/biosapien |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated